Rigel Pharmaceuticals (RIGL) Q4 2024 Earnings

7NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.5
-0.1
0.3
0.7

Details

Expected EPS
0.058476
Actual EPS
0.7
Surprise EPS
0.64
Surprise Percent
+1,097.07%

Description

Rigel Pharmaceuticals (RIGL) has reported earnings of 0.7 per share for Q4 2024.

0 Comments

Share your thoughts